|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Biofield Corp. (BZET)'s Master Licensee to Consummate CareLife China Joint Ventures at Signing Ceremony on June 16
6/4/2008 8:26:50 AM
HONG KONG--(BUSINESS WIRE)--Biofield Corp. (OTC: BZET) today reported that its master licensee, MacKay Group Limited (MKG), will consummate the Chinese healthcare joint ventures with the authorized agent for Shanghai Jiashen Lifecare Investment Management Company Limited (CareLife) on June 16 at a signing ceremony covered by media in mainland China and Hong Kong. A lease has been signed for a new China HQ at an exclusive government owned building in Shanghai. The new China HQ will oversee and manage the Carelife JVs, which will distribute, test, further develop, and gather critical medical data from the Biofield Diagnostic System (BDS) and other medical technology in conjunction with leading Chinese governmental healthcare organizations, hospitals, testing centers, doctors, medical organizations, insurance companies, and banks.
|
|
|
|
|
|
|
|
|
|
|